Skip to main content
Caplight Logo









Cryptyx Bioscience

Cryptyx Bioscience

Private
Princeton, New JerseyHealthcare & Life Scienceshttps://www.cryptyxbioscience.com/

Last Round

Grant

Sep 1, 2024

Total Funding Raised

$2.25M

Company Overview

Cryptyx Bioscience is a biotechnology company that develops a genetics-free, cloning-free, bioactivity-first drug discovery platform to identify novel antibiotics and antiviral drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Non-AI

Keywords

drug discoverybiotechnologyhigh-throughput elicitor screeningHiTESsmall molecule discoverynatural productspreclinical researchwet-lab platformtherapeutic pipelinedrug developmentmicrobial genomicsbiotech startupdrug discovery servicesasset licensingSBIR grants

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cryptyx Bioscience Comparables

Compare Cryptyx Bioscience with similar companies based on industry and business-model similarity.

Cryptyx Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ArrePath
77%
Terrapeutics Pharma
74%
Chiromics LLC
71%

Cryptyx Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2024
GrantJun 1, 2024
AcceleratorDec 1, 2023
AngelApr 1, 2023
GrantApr 1, 2022
Grant
Aug 1, 2021

Cryptyx Bioscience Investors

Notable investors and investment history

Cryptyx Bioscience investors
InvestorRounds
VITAL HubAccelerator
Princeton University Investment CompanyGrant
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2024

    $999K grant received from the National Science Foundation.

  • Jun 1, 2024

    $999K grant from the National Science Foundation.

Cryptyx Bioscience Filings

Explore SEC and related filing metadata, where available.

Cryptyx Bioscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cryptyx Bioscience's valuation, stock price, and market status.

Is Cryptyx Bioscience a public or private company?

Cryptyx Bioscience is a private company.

What is the current stock price of Cryptyx Bioscience?

Cryptyx Bioscience is a private company with no public stock price. No recent secondary market data is available.

How much is Cryptyx Bioscience worth (valuation)?

Valuation information for Cryptyx Bioscience is not publicly available.

Can I buy Cryptyx Bioscience stock?

Cryptyx Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cryptyx Bioscience's last funding round?

Cryptyx Bioscience's most recent funding round was Grant on September 15, 2025.

Who are the main investors in Cryptyx Bioscience?

Key investors in Cryptyx Bioscience include Princeton University, National Science Foundation.

Will Cryptyx Bioscience IPO soon?

No public IPO plans have been announced for Cryptyx Bioscience.

How can I track Cryptyx Bioscience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cryptyx Bioscience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPrinceton, New Jersey
Employee Range1
Year Founded2020
Last FundingSep 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?